Publications

  1. Su M, Jiang Y, Zhao C, Cai Y, Zhang W, Liu J, Tang H, Yan L, Xu Z, Goel A, Kumar A, Asrani S, Shaw J, Vargas H, Keaveny A, Cao Z, Wong F, Choudhury AK, Kamath PS, Topazian M, Torre A, Hayes PC, George J, Idilman R, Seto WK, Desalegn H, Alvares-da-Silva MR, Bush BJ, Thacker LR, Xie Q, Bajaj JS, CLEARED Consortium. Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium. Lancet Gastroenterol Hepatol. 2024 Nov; 9 (11):997-1009 Epub 2024 Sept 05
    View PubMed
  2. Caldera F, Singh S, Zona EE, Ramirez Ramirez O, Inselman J, Heien H, Keaveny AP, Hayney MS, Farraye FA. Patients with Inflammatory Bowel Disease are at Increased Risk for Complications of Herpes Zoster. Clin Gastroenterol Hepatol. 2024 Oct 24 [Epub ahead of print]
    View PubMed
  3. Ashmila H, Khatoon N, Keaveny A, Krishna M, Nakhleh R. Intrinsic Causes of Nonfibrotic Portal Hypertension-A Clinicopathologic Review of 56 Patients. Int J Surg Pathol. 2024 Aug 21; 10668969241268406 [Epub ahead of print]
    View PubMed
  4. Prier CC, Hedges MS, Tolaymat LM, Walker AL, Haga C, Craver EC, Heckman MG, Yin M, McManus M, Dawson N, Keaveny AP. Impact of Religious Affiliation on Clinical Outcomes in Liver Transplant Patients. Cureus. 2024 Aug; 16 (8):e66372 Epub 2024 Aug 07
    View PubMed
  5. Hassanein T, Keaveny AP, Mantry P, Smith AD, McRae MP, Kittelson J, Helmke S, Everson GT, SHUNT-V Investigators. Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices. Aliment Pharmacol Ther. 2024 Jul; 60 (2):246-256 Epub 2024 May 22
    View PubMed
  6. Attieh RM, Ibrahim RM, Ghali P, Keaveny A, Croome K, Hodge D, White L, Wadei HM. Improved outcomes of kidney after liver transplantation after the implementation of the safety net policy. Liver Transpl. 2024 Jun 1; 30 (6):582-594 Epub 2023 Nov 29
    View PubMed
  7. Bajaj JS, Kamath PS, Reddy KR, Asrani SK, Keaveny AP, Tandon P, Duarte-Rojo A, Kappus M, Verna E, Biggins SW, Vargas HE, Albhaisi S, Shaw J, Dahiya M, Filipek N, Fallahzadeh MA, Wegermann K, Cabello R, Bera C, Thuluvath P, Bush B, Thacker LR, Wong F. Predictors of Respiratory Failure Development in a Multicenter Cohort of Inpatients With Cirrhosis. Am J Gastroenterol. 2024 Apr 1; 119 (4):712-718 Epub 2023 Nov 08
    View PubMed
  8. Loeb L, Lewis J, Peng Z, Heckman MG, Nakhleh R, Keaveny AP. A clinical review of congenital hepatic fibrosis diagnosed in adulthood: presentation, complications, and outcomes. Ann Hepatol. 2024 Jan-Feb; 29 (1):101164 Epub 2023 Oct 04
    View PubMed
  9. Wang Y, Huang Y, Chase RC, Li T, Ramai D, Li S, Huang X, Antwi SO, Keaveny AP, Pang M. Global Burden of Digestive Diseases: A Systematic Analysis of the Global Burden of Diseases Study, 1990 to 2019. Gastroenterology. 2023 Sep; 165 (3):773-783.e15 Epub 2023 June 09
    View PubMed
  10. Zaver HB, Mzaik O, Thomas J, Roopkumar J, Adedinsewo D, Keaveny AP, Patel T. Utility of an Artificial Intelligence Enabled Electrocardiogram for Risk Assessment in Liver Transplant Candidates. Dig Dis Sci. 2023 Jun; 68 (6):2379-2388 Epub 2023 Apr 06
    View PubMed
  11. Niazi SK, Brennan E, Spaulding A, Crook J, Borkar S, Keaveny A, Vasquez A, Gentry MT, Schneekloth T, Taner CB. Impact of Recipient Age at Liver Transplant on Long-term Outcomes. Transplantation. 2023 Mar 1; 107 (3):654-663 Epub 2022 Nov 10
    View PubMed
  12. Khatoon N, Keaveny AP, Carames GP, Krishna M, Lewis J, Nakhleh RE. Hepatoportal Sclerosis-A Clinicopathologic Review of 28 Cases. Gastro Hep Adv. 2023; 2 (3):303-306 Epub 2023 Jan 11
    View PubMed
  13. Cajigas HR, Burger CD, Cartin-Ceba R, DuBrock H, Swanson K, Vargas HE, Keaveny AP, Watt KD, Krowka M. Portopulmonary Hypertension in Nontransplanted Patients: Results of the Largest US Single-Institution Registry. Mayo Clin Proc. 2022 Dec; 97 (12):2236-2247 Epub 2022 Nov 03
    View PubMed
  14. Aragon Pinto C, Iyer V, Almodallal YA, Albitar H, Dubrock H, Cajigas H, Heimbach JK, Rosen CB, Watt K, Taner T, Nyberg S, Vargas H, Cartin-Ceba R, Keaveny AP, Krowka M, Gallo de Moraes A. ICU and Hospital Outcomes in Patients with Hepatopulmonary Syndrome Undergoing Liver Transplantation. Lung. 2022 Feb; 200 (1):5-10 Epub 2022 Jan 10
    View PubMed
  15. Cordova-Gallardo J, Keaveny AP, Qi X, Mendez-Sanchez N. Metabolic associated fatty liver disease and acute-on-chronic liver failure: common themes for common problems. Eur J Gastroenterol Hepatol. 2021 Dec 1; 33 (1S Suppl 1):e84-e93
    View PubMed
  16. Niazi SK, Vargas E, Spaulding A, Crook J, Keaveny AP, Schneekloth T, Rummans T, Taner CB. Impact of County Health Rankings on Nationwide Liver Transplant Outcomes. Transplantation. 2021 Nov 1; 105 (11):2411-2419
    View PubMed
  17. Cartin-Ceba R, Burger C, Swanson K, Vargas H, Aqel B, Keaveny AP, Heimbach J, Taner T, Nyberg S, Rosen C, Cajigas H, DuBrock H, Krowka MJ. Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension. Transplantation. 2021 Oct 1; 105 (10):2283-2290
    View PubMed
  18. Wadei HM, Keaveny AP, Taner CB, Yang L, Mai ML, Hodge DO, White LJ, Mao SA, Jarmi T, Croome KP. Post-Liver Transplant Early Allograft Dysfunction Modifies the Effect of Pre-Liver Transplant Renal Dysfunction on Post-Liver Transplant Survival. Liver Transpl. 2021 Sep; 27 (9):1291-1301 Epub 2021 July 21
    View PubMed
  19. Wadei HM, Burcin Taner C, Keaveny AP, Mai ML, Hodge DO, White LJ, Harnois DM, Mao SA, Jarmi T, Croome KP. The changing impact of pre-liver transplant renal dysfunction on post-transplant survival: results of 2 decades from a single center. Ann Hepatol. 2021 Sep-Oct; 24:100317 Epub 2021 Feb 03
    View PubMed
  20. Tolaymat LM, Reimer DK, Feig J, Gillis MS, Speicher LL, Haga CB, Gabriel EM, Heckman MG, Yin M, Fosko SW, Keaveny AP, Dawson NL. Skin cancer in non-white liver transplant recipients: Mayo Clinic experience. Int J Dermatol. 2021 Aug; 60(8):986-990. Epub 2021 Mar 20.
    View PubMed
  21. Liou H, Mody K, Boyle AW, Keaveny AP, Croome KP, Burns JM, Harnois DM, Patel TC, Toskich B. Neoadjuvant Radiation Lobectomy and Immunotherapy for Angioinvasive HCC Resulting in Complete Pathologic Response. Hepatology. 2021 Jul; 74 (1):525-527 Epub 2021 Apr 27
    View PubMed
  22. Wijarnpreecha K, Scribani M, Raymond P, Harnois DM, Keaveny AP, Ahmed A, Kim D. PNPLA3 Gene Polymorphism and Liver- and Extrahepatic Cancer-Related Mortality in the United States. Clin Gastroenterol Hepatol. 2021 May; 19 (5):1064-1066 Epub 2020 Apr 29
    View PubMed
  23. Yataco ML, Bowman AW, Keaveny AP. Management of the Incidental Liver Lesion. Am J Gastroenterol. 2021 May 1; 116 (5):855-861
    View PubMed
  24. Croome KP, Livingston D, Croome S, Keaveny AP, Taner CB, Nakhleh R. Sequential Protocol Biopsies Post-Liver Transplant From Donors With Moderate Macrosteatosis: What Happens to the Fat? Liver Transpl. 2021 Feb; 27 (2):248-256
    View PubMed
  25. Tse CS, Yang JD, Mousa OY, Nelson KM, Pungpapong S, Keaveny A, Aqel BA, Vargas H, Dickson RC, Watt K, Gores GJ, Roberts LR, Leise MD. Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C. Transplant Direct. 2021 Jan; 7(1):e635. Epub 2020 Dec 08.
    View PubMed
  26. Corral JE, Croome KP, Keaveny AP, Brahmbhatt B, Kroner PT, Bartel MJ, Wijarnpreecha K, Goswami RM, Raimondo M, Wallace MB, Bi Y, Mousa OY. A 3-Decade Analysis of Pancreatic Adenocarcinoma After Solid Organ Transplant. Pancreas. 2021 Jan 1; 50 (1):54-63
    View PubMed
  27. Wijarnpreecha K, Scribani M, Raymond P, Harnois DM, Keaveny AP, Ahmed A, Kim D. PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States. J Gastroenterol Hepatol. 2020 Oct; 35 (10):1789-1794 Epub 2020 Apr 12
    View PubMed
  28. Chaney A, Rawal B, Harnois D, Keaveny A. Nutritional Assessment and Malnutrition in Patients With Cirrhosis. Gastroenterol Nurs. 2020 Jul/Aug; 43 (4):284-291
    View PubMed
  29. Racho RG, Krishna M, Canabal JM, Keaveny AP. Liver Transplantation for Acute Liver Failure Secondary to Acute Sickle Intrahepatic Cholestasis. Am J Gastroenterol. 2020 Jun; 115 (6):809
    View PubMed
  30. Wijarnpreecha K, Lou S, Watthanasuntorn K, Kroner PT, Cheungpasitporn W, Lukens FJ, Pungpapong S, Keaveny AP, Ungprasert P. Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2020 May; 32 (5):601-608
    View PubMed
  31. Wadei HM, Abader P, Alsaad AA, Croome K, Cortese C, Geiger XJ, Khouzam S, Mai ML, Taner CB, Keaveny AP. Arterial Blood Pressure at Liver Transplant Evaluation Predicts Renal Histology in Candidates With Renal Dysfunction. Liver Transpl. 2019 Dec; 25 (12):1756-1767 Epub 2019 Oct 31
    View PubMed
  32. Croome KP, Lee DD, Croome S, Chadha R, Livingston D, Abader P, Keaveny AP, Taner CB. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis. Am J Transplant. 2019 Sep; 19 (9):2550-2559 Epub 2019 Mar 26
    View PubMed
  33. Ferman TJ, Keaveny AP, Schneekloth T, Heckman MG, Vargas E, Vasquez A, Rummans T, Taner CB, Niazi SK. Liver Transplant Recipients Older Than 60 Years Show Executive and Memory Function Improvement Comparable to Younger Recipients. Psychosomatics. 2019 Sep - Oct; 60 (5):488-498 Epub 2019 Jan 23
    View PubMed
  34. Loh CA, Croome KP, Burcin Taner C, Keaveny AP. Bias-corrected estimates of reduction of post-surgery length of stay and corresponding cost savings through the widespread national implementation of fast-tracking after liver transplantation: a quasi-experimental study. J Med Econ. 2019 Jul; 22 (7):684-690 Epub 2019 Apr 02
    View PubMed
  35. Palmer WC, Taner CB, Keaveny AP, Nakhleh RE, Nguyen JH, Rosser BG Jr. Antithymocyte Globulin Use for Corticosteroid Nonresponsive Rejection After Liver Transplantation. Transplant Proc. 2018 Dec; 50 (10):3606-3614 Epub 2018 Sept 08
    View PubMed
  36. Koop AH, Mousa OY, Pham LE, Corral-Hurtado JE, Pungpapong S, Keaveny AP. An Argument for Vitamin D, A, and Zinc Monitoring in Cirrhosis. Ann Hepatol. 2018 Nov - Dec; 17 (6):920-932
    View PubMed
  37. Koop AH, Mousa OY, Pham LE, Corral-Hurtado JE, Pungpapong S, Keaveny AP. An Argument for Vitamin D, A, and Zinc Monitoring in Cirrhosis. Ann Hepatol. 2018 Oct 16; 17 (6):920-932
    View PubMed
  38. Chascsa DM, Mousa OY, Pungpapong S, Zhang N, Chervenak A, Nidamanuri S, Rodriguez E, Franco D, Ryland K, Keaveny AP, Huskey JL, Smith M, Reddy KS, Taner CB, Vargas HE, Aqel BA. Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study. Am J Transplant. 2018 Oct; 18 (10):2559-2565 Epub 2018 June 08
    View PubMed
  39. Alsaad AA, Stancampiano FF, Palmer WC, Henry AM, Jackson JK, Ms MGH, Diehl NN, Keaveny AP. Serum Electrolyte Levels and Outcomes in Patients Hospitalized with Hepatic Encephalopathy. Ann Hepatol. 2018 Sep - Oct; 17 (5):836-842
    View PubMed
  40. Aqel B, Leise M, Vargas HE, Watt KD, Keaveny AP, Zhang N, Pungpapong S. Multicenter Experience using Ledipasvir/Sofosbuvir +/- RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment. Ann Hepatol. 2018 Sep - Oct; 17 (5):815-821
    View PubMed
  41. Aqel B, Leise M, Vargas HE, Watt KD, Keaveny AP, Zhang N, Zhang N, Pungpapong S. Multicenter Experience using Ledipasvir/Sofosbuvir +/- RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment. Ann Hepatol. 2018 Aug 24; 17 (5):815-821
    View PubMed
  42. Alsaad AA, Stancampiano FF, Palmer WC, Henry AM, Jackson JK, Heckman MG, Diehl NN, Keaveny AP. Serum Electrolyte Levels and Outcomes in Patients Hospitalized with Hepatic Encephalopathy. Ann Hepatol. 2018 Aug 24; 17 (5):836-842
    View PubMed
  43. Niazi SK, Schneekloth TD, Vasquez AR, Keaveny AP, Davis S, Picco M, Heckman MG, Diehl NN, Jowsey-Gregoire SG, Rummans TA, Burcin Taner C. Impact of psychiatric comorbidities on outcomes of elderly liver transplant recipients. J Psychosom Res. 2018 Aug; 111:27-35 Epub 2018 May 17
    View PubMed
  44. Wadei HM, Lee DD, Croome KP, Mai L, Leonard D, Mai ML, Taner CB, Keaveny AP. Early Allograft Dysfunction Is Associated With Higher Risk of Renal Nonrecovery After Liver Transplantation. Transplant Direct. 2018 Apr; 4 (4):e352 Epub 2018 Mar 14
    View PubMed
  45. Croome KP, Lee DD, Pungpapong S, Keaveny AP, Taner CB. What are the outcomes of declining a public health service increased risk liver donor for patients on the liver transplant waiting list? Liver Transpl. 2018 Apr; 24 (4):497-504
    View PubMed
  46. Croome KP, Lee DD, Burns JM, Keaveny AP, Taner CB. Intraregional model for end-stage liver disease score variation in liver transplantation: Disparity in our own backyard. Liver Transpl. 2018 Apr; 24 (4):488-496
    View PubMed
  47. Brumble L, Keaveny AP. Editorial: The Risky Business of Fungal Infections in Patients with Cirrhosis. Am J Gastroenterol 2018 Apr; 113 (4):564-566
    View PubMed
  48. Taner CB, Keaveny AP. Innovative care models after liver transplant. Clin Liver Dis (Hoboken). 2017 Sep; 10 (3):68-71 Epub 2017 Sept 29
    View PubMed
  49. Croome KP, Lee DD, Nguyen JH, Keaveny AP, Taner CB. Waitlist Outcomes for Patients Relisted Following Failed Donation After Cardiac Death Liver Transplant: Implications for Awarding Model for End-Stage Liver Disease Exception Scores. Am J Transplant. 2017 Sep; 17 (9):2420-2427 Epub 2017 July 07
    View PubMed
  50. Croome KP, Lee DD, Keaveny AP, Taner CB. Noneligible Donors as a Strategy to Decrease the Organ Shortage. Am J Transplant. 2017 Jun; 17 (6):1649-1655 Epub 2017 Jan 31
    View PubMed
  51. Palmer WC, Lee D, Burns J, Croome K, Rosser B, Patel T, Keaveny AP, Pungpapong S, Satyanarayana R, Yataco M, Nakhleh R, Musto KR, Canabal AM, Turnage AK, Hodge DO, Nguyen JH, Harnois DM. Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center. Ann Hepatol. 2017 May - Jun; 16 (3):402-411
    View PubMed
  52. Palmer WC, Lee D, Burns J, Croome K, Rosser B, Patel T, Keaveny AP, Pungpapong S, Satyanarayana R, Yataco M, Nakhleh R, Musto KR, Canabal AM, Turnage AK, Hodge DO, Nguyen JH, Harnois DM. Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center. Ann Hepatol. 2017 May - Jun; 16 (3):402-411
    View PubMed
  53. Croome KP, Lee DD, Perry DK, Burns JM, Nguyen JH, Keaveny AP, Taner CB. Comparison of longterm outcomes and quality of life in recipients of donation after cardiac death liver grafts with a propensity-matched cohort. Liver Transpl. 2017 Mar; 23 (3):342-351
    View PubMed
  54. Croome KP, Lee DD, Keaveny AP, Taner CB. Improving National Results in Liver Transplantation Using Grafts From Donation After Cardiac Death Donors. Transplantation. 2016 Dec; 100 (12):2640-2647
    View PubMed
  55. Croome KP, Lee DD, Burns JM, Perry DK, Nguyen JH, Keaveny AP, Wadei HM, Taner CB. Simultaneous liver and kidney transplantation in elderly patients Outcomes and validation of a clinical risk score for patient selection..2016;().
  56. Croome KP, Lee DD, Burns JM, Perry DK, Nguyen JH, Keaveny AP, Wadei HM, Taner CB. Simultaneous liver and kidney transplantation in elderly patients: Outcomes and validation of a clinical risk score for patient selection. Ann Hepatol. 2016 Nov - Dec; 15 (6):870-880
    View PubMed
  57. Yataco M, Cowell A, David W, Keaveny AP, Taner CB, Patel T. Predictors and impacts of hospital readmissions following liver transplantation. Ann Hepatol. 2016 May-Jun; 15 (3):356-62
    View PubMed
  58. Singh S, Venkatesh SK, Keaveny A, Adam S, Miller FH, Asbach P, Godfrey EM, Silva AC, Wang Z, Murad MH, Asrani SK, Lomas DJ, Ehman RL. Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysis. Ann Hepatol. 2016 May-Jun; 15 (3):363-76
    View PubMed
  59. Singh S, Venkatesh SK, Keaveny A, Adam S, Miller FH, Asbach P, Godfrey EM, Silva AC, Wang Z, Murad MH, Asrani SK, Lomas DJ, Ehman RL. Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysis. Ann Hepatol. 2016 May-Jun; 15 (3):363-76
    View PubMed
  60. Yataco M, Cowell A, David W, Keaveny AP, Taner CB, Patel T. Predictors and impacts of hospital readmissions following liver transplantation. Ann Hepatol. 2016 May - Jun; 15 (3):356-362
    View PubMed
  61. Singh S, Venkates SK, Keaveny A, Adam S, Miller FH, Asbach P, Godfrey EM, Silva AC, Wang Z, Murad MH, Asrani SK, Lomas DJ, Ehman RL. Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysis. Ann Hepatol. 2016 May - Jun; 15 (3):363-376
    View PubMed
  62. Wadei HM, Lee DD, Croome KP, Mai ML, Golan E, Brotman R, Keaveny AP, Taner CB. Early Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment. Am J Transplant. 2016 Mar; 16 (3):850-9 Epub 2015 Dec 11
    View PubMed
  63. Lee DD, Croome KP, Shalev JA, Musto KR, Sharma M, Keaveny AP, Taner CB. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements. Ann Hepatol. 2016 Jan-Feb; 15 (1):53-60
    View PubMed
  64. Lee DD, Croome KP, Shalev JA, Musto KR, Sharma M, Keaveny AP, Taner CB. Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements. Ann Hepatol. 2016 Jan - Feb; 15 (1):53-60
    View PubMed
  65. Giesbrandt KJ, Bulatao IG, Keaveny AP, Nguyen JH, Paz-Fumagalli R, Taner CB. Radiologic Characterization of Ischemic Cholangiopathy in Donation-After-Cardiac-Death Liver Transplants and Correlation With Clinical Outcomes. AJR Am J Roentgenol. 2015 Nov; 205 (5):976-84
    View PubMed
  66. Aqel BA, Pungpapong S, Leise M, Werner KT, Chervenak AE, Watt KD, Murphy JL, Ryland K, Keaveny AP, McLemore R, Vargas HE. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis. Hepatology. 2015 Oct; 62 (4):1004-12 Epub 2015 Aug 07
    View PubMed
  67. Ngamruengphong S, Horsley-Silva JL, Hines SL, Pungpapong S, Patel TC, Keaveny AP. Educational Intervention in Primary Care Residents' Knowledge and Performance of Hepatitis B Vaccination in Patients with Diabetes Mellitus. South Med J. 2015 Sep; 108: (9)510-5.
    View PubMed
  68. Pungpapong S, Aqel B, Leise M, Werner KT, Murphy JL, Henry TM, Ryland K, Chervenak AE, Watt KD, Vargas HE, Keaveny AP. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant. Hepatology. 2015 Jun; 61 (6):1880-6 Epub 2015 Apr 27
    View PubMed
  69. Ngamruengphong S, Seeger KM, McCrone LM, Moris M, Garrison SJ, Pungpapong S, Keaveny AP, Raimondo M. Prevalence and outcomes of cystic lesion of the pancreas in immunosuppressed patients with solid organ transplantation. Dig Liver Dis. 2015 May; 47: (5)417-22.
    View PubMed
  70. Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, Asbach P, Godfrey EM, Yin M, Chen J, Keaveny AP, Bridges M, Bohte A, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol. 2015 Mar; 13 (3):440-451.e6 Epub 2014 Nov 20
    View PubMed
  71. Croome KP, Lee DD, Burns JM, Perry DK, Keaveny AP, Taner CB. Patterns and Outcomes Associated with Patient Migration for Liver Transplantation in the United States. PLoS One. 2015; 10 (10):e0140295 Epub 2015 Oct 15
    View PubMed
  72. Wadei HM, Heckman MG, Rawal B, Taner CB, Mai ML, Cortese C, Rosser BG, Gonwa TA, Keaveny AP. Renal outcomes of liver transplant recipients who had pretransplant kidney biopsy. Transplantation. 2014 Dec 27; 98(12):1323-30.
    View PubMed
  73. Wallace MB, Crook JE, Coe S, Ussui V, Staggs E, Almansa C, Patel MK, Bouras E, Cangemi J, Keaveny A, Picco M, Riegert-Johnson D. Accuracy of in vivo colorectal polyp discrimination by using dual-focus high-definition narrow-band imaging colonoscopy. Gastrointest Endosc. 2014 Dec; 80 (6):1072-87 Epub 2014 June 25
    View PubMed
  74. Bulatao IG, Heckman MG, Rawal B, Aniskevich S, Shine TS, Keaveny AP, Perry DK, Canabal J, Willingham DL, Taner CB. Avoiding stay in the intensive care unit after liver transplantation: a score to assign location of care. Am J Transplant. 2014 Sep; 14 (9):2088-96 Epub 2014 Aug 01
    View PubMed
  75. Sheikh-Ali M, Keaveny AP, Chamseddin A, Aguirre L, Clarke B, Meek S. 25-Hydroxyvitamin D levels and acute cellular rejection in liver transplant patients. Endocr Pract. 2014 Aug; 20 (8):769-74
    View PubMed
  76. Wadei HM, Bulatao IG, Gonwa TA, Mai ML, Prendergast M, Keaveny AP, Rosser BG, Taner CB. Inferior long-term outcomes of liver-kidney transplantation using donation after cardiac death donors: single-center and organ procurement and transplantation network analyses. Liver Transpl. 2014 Jun; 20(6):728-35.
    View PubMed
  77. Lee DD, Croome KP, Perry DK, Burns JM, Nguyen JH, Keaveny AP, Taner CB. Liver Transplantation at Mayo Clinic Florida. Clin Transpl. 2014; 83-90.
    View PubMed
  78. Crespo S, Bridges M, Nakhleh R, McPhail A, Pungpapong S, Keaveny AP. Non-invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C. Clin Transplant. 2013 Sep-Oct; 27: (5)652-8.
    View PubMed
  79. Pungpapong S, Aqel BA, Koning L, Murphy JL, Henry TM, Ryland KL, Yataco ML, Satyanarayana R, Rosser BG, Vargas HE, Charlton MR, Keaveny AP. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation. Liver Transpl. 2013 Jul; 19 (7):690-700 Epub 2013 June 03
    View PubMed
  80. Wadei HM, Zaky ZS, Keaveny AP, Rosser B, Jones M, Mai ML, Bulatao I, Gonwa TA. Proteinuria following sirolimus conversion is associated with deterioration of kidney function in liver transplant recipients. Transplantation. 2012 May 27; 93(10):1006-12.
    View PubMed
  81. Taner CB, Bulatao IG, Willingham DL, Perry DK, Sibulesky L, Pungpapong S, Aranda-Michel J, Keaveny AP, Kramer DJ, Nguyen JH. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl. 2012 Jan; 18 (1):100-11
    View PubMed
  82. Taner CB, Bulatao IG, Keaveny AP, Willingham DL, Pungpapong S, Perry DK, Rosser BG, Harnois DM, Aranda-Michel J, Nguyen JH. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl. 2011 Jun; 17 (6):641-9
    View PubMed
  83. Dickson RC, Pungpapong S, Keaveny AP, Taner CB, Ghabril M, Aranda-Michel J, Satyanarayana R, Bonatti H, Kramer DJ, Nguyen JH. Improving graft survival for patients undergoing liver transplantation. Clin Transplant. 2011 May-Jun; 25(3):E345-55. Epub 2011 Mar 23.
    View PubMed
  84. Taner CB, Balci D, Willingham DL, Keaveny AP, Rosser BG, Canabal JM, Shine TS, Harnois DM, Kramer DJ, Nguyen JH. Long-term outcomes after third liver transplant. Exp Clin Transplant. 2011 Apr; 9(2):98-104.
    View PubMed
  85. Begum R, Harnois D, Satyanarayana R, Krishna M, Halling KC, Kim GP, Nguyen JH, Keaveny AP. Retransplantation for donor-derived neuroendocrine tumor. Liver Transpl. 2011 Jan; 17(1):83-7.
    View PubMed
  86. Hughes CB, Dickson RC, Krishna M, Willingham DL, Satyanarayana R, Harnois DM, Keaveny AP, Rosser B, Aranda-Michel J, Kramer DJ, Hellinger W, Mendez J. HCV recurrence in HIV-infected patients after liver transplant. J Int Assoc Physicians AIDS Care (Chic). 2010 Mar-Apr; 9(2):87-93. Epub 2010 Mar 31.
    View PubMed
  87. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, Rosser BG, Keaveny AP, Aranda-Michel J, Satyanarayana R, Harnois D, Dickson RC, Kramer DJ, Hughes CB. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl. 2009 Sep; 15 (9):1028-35
    View PubMed
  88. Gill KR, Pelaez-Luna M, Keaveny A, Woodward TA, Wallace MB, Chari ST, Smyrk TC, Takahashi N, Clain JE, Levy MJ, Pearson RK, Petersen BT, Topazian MD, Vege SS, Kendrick M, Farnell MB, Raimondo M. Branch duct intraductal papillary mucinous neoplasm of the pancreas in solid organ transplant recipients. Am J Gastroenterol. 2009 May; 104(5):1256-61. Epub 2009 Apr 07.
    View PubMed
  89. Ghabril M, Dickson RC, Krishna M, Bonatti H, Aranda-Michel J, Keaveny AP, Satyanarayana R, Hewitt W, Hughes CB, Nguyen JH. Liver transplantation using young pediatric donor grafts in adults with hepatitis C infection. Transplantation. 2009 Apr 27; 87(8):1174-9.
    View PubMed
  90. Nguyen JH, Bonatti H, Dickson RC, Hewitt WR, Grewal HP, Willingham DL, Harnois DM, Schmitt TM, Machicao VI, Ghabril MS, Keaveny AP, Aranda-Michel J, Satyanarayana R, Rosser BG, Hinder RA, Steers JL, Hughes CB. Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant. 2009 Mar-Apr; 23(2):168-73. Epub 2009 Feb 11.
    View PubMed
  91. Keaveny AP, Sigal SS. Effect of Hepatorenal syndrome resolution on transplant and transplant-free outcomes. US Gastroenterology and Hepatology Review. 2009; 5:31-36.
  92. Ghabril M, Dickson RC, Krishna M, Lloyd R, Aranda-Michel J, Keaveny A, Satyanarayana R, Bonatti H. Persistence of hepatitis C RNA in liver allografts is associated with histologic progression independent of serologic viral clearance. J Transplant. 2009; 2009:297528. Epub 2009 May 05.
    View PubMed
  93. Wadei HM, Geiger XJ, Cortese C, Mai ML, Kramer DJ, Rosser BG, Keaveny AP, Willingham DL, Ahsan N, Gonwa TA. Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy. Am J Transplant. 2008 Dec; 8 (12):2618-26
    View PubMed
  94. Pungpapong S, Nunes DP, Krishna M, Nakhleh R, Chambers K, Ghabril M, Dickson RC, Hughes CB, Steers J, Nguyen JH, Keaveny AP. Serum fibrosis markers can predict rapid fibrosis progression after liver transplantation for hepatitis C. Liver Transpl. 2008 Sep; 14: (9)1294-302.
    View PubMed
  95. Aranda-Michel J, Dickson RC, Bonatti H, Crossfield JR, Keaveny AP, Vasquez AR. Patient selection for liver transplant: 1-year experience with 555 patients at a single center. Mayo Clin Proc. 2008 Feb; 83(2):165-8.
    View PubMed
  96. Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival. Liver Transpl. 2007 Dec; 13(12):1717-27.
    View PubMed
  97. Pungpapong S, Keaveny A, Raimondo M, Dickson R, Woodward T, Harnois D, Wallace M. Accuracy and interobserver agreement of small-caliber vs. conventional esophagogastroduodenoscopy for evaluating esophageal varices. Endoscopy. 2007 Aug; 39(8):673-80. Epub 2007 Jun 22.
    View PubMed
  98. Pungpapong S, Alvarez S, Hellinger WC, Kramer DJ, Willingham DL, Mendez JC, Nguyen JH, Hewitt WR, Aranda-Michel J, Harnois DM, Rosser BG, Hughes CB, Grewal HP, Satyanarayana R, Dickson RC, Steers JL, Keaveny AP. Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome. Liver Transpl. 2006 Aug; 12(8):1244-52.
    View PubMed
  99. Pungpapong S, Steers JL, Wallace MB, Krishna M, Keaveny AP. Hepatobiliary sarcoidosis mimicking Klatskin's cholangiocarcinoma. Gastrointest Endosc. 2006 Jul; 64(1):124-5.
    View PubMed
  100. Pungpapong S, Krishna M, Abraham SC, Keaveny AP, Dickson RC, Nakhleh RE. Clinicopathologic findings and outcomes of liver transplantation using grafts from donors with unrecognized and unusual diseases. Liver Transpl. 2006 Feb; 12(2):310-5.
    View PubMed
  101. Krishna M, Keaveny AP, Genco PV, Rosser BG, Dickson RC, Nguyen JH, Steers JL, Nakhleh RE. Clinicopathological review of 18 cases of liver allografts lost due to bile duct necrosis. Transplant Proc. 2005 Jun; 37(5):2221-3.
    View PubMed
  102. Nakhleh RE, Krishna M, Keaveny AP, Dickson RC, Rosser B, Nguyen JH, Steers JL. Review of 31 cases of morphologic hepatitis in liver transplant patients not related to disease recurrence. Transplant Proc. 2005 Mar; 37(2):1240-2.
    View PubMed
  103. Keaveny AP, Gordon FD, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, Jenkins RL, Khettry U. Native liver xanthogranulomatous cholangiopathy in primary sclerosing cholangitis: impact on posttransplant outcome. Liver Transpl.. 2004 Jan; 10: (1)115-22.
    View PubMed
  104. Khettry U, Keaveny A, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, Jenkins RL, Gordon FD. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study. Hum Pathol. 2003 Nov; 34(11):1127-36.
    View PubMed
  105. O'Brien MJ, Keating NM, Elderiny S, Cerda S, Keaveny AP, Afdhal NH, Nunes DP. An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. Am J Clin Pathol. 2000 Nov; 114(5):712-8.
    View PubMed
  106. Keaveny AP, Offner GD, Bootle E, Nunes DP. No significant difference in antigenicity or tissue transglutaminase substrate specificity of Irish and US wheat gliadins. Dig Dis Sci. 2000 Apr; 45(4):755-62.
    View PubMed
  107. Keaveny AP, Karasik MS, Farber HW. Successful treatment of chylous ascites secondary to Mycobacterium avium complex in a patient with the acquired immune deficiency syndrome. Am J Gastroenterol. 1999 Jun; 94(6):1689-90.
    View PubMed
  108. Keaveny AP, Karasik MS. Hepatobiliary and pancreatic infections in AIDS: Part II. AIDS Patient Care STDS. 1998 Jun; 12(6):451-6.
    View PubMed
  109. Keaveny AP, Karasik MS. Hepatobiliary and pancreatic infections in AIDS: Part one. AIDS Patient Care STDS. 1998 May; 12(5):347-57.
    View PubMed
  110. Afdhal NH, Keaveny AP, Cohen SB, Nunes DP, Maldonado N, O'Brien M, Stone PJ. Urinary assays for desmosine and hydroxylysylpyridinoline in the detection of cirrhosis. J Hepatol. 1997 Dec; 27(6):993-1002.
    View PubMed
  111. Salomons H, Keaveny AP, Henihan R, Offner G, Sengupta A, Lamorte WW, Afdhal NH. Nitric oxide and gallbladder motility in prairie dogs. Am J Physiol. 1997 Apr; 272(4 Pt 1):G770-8.
    View PubMed
  112. Keaveny AP, Freaney R, McKenna MJ, Masterson J, O'Donoghue DP. Bone remodeling indices and secondary hyperparathyroidism in celiac disease. Am J Gastroenterol. 1996 Jun; 91(6):1226-31.
    View PubMed